多发性骨髓瘤特异性主动免疫治疗研究新进展
摘要
多发性骨髓瘤（MM）是一种起源于浆细胞的血液系统恶性肿瘤，MM患者的免疫系统存在多种缺陷。抗肿瘤免疫治疗已证实耐受良好并且不太可能与目前的化疗药产生交叉耐药。近年来的多项临床前试验和临床试验已证实，免疫治疗有望延长MM患者生存期、改善疾病结果。笔者现就近年来MM特异性主动免疫治疗的研究新进展作一综述。
出处
《国际输血及血液学杂志》
CAS
2013年第3期251-254,共4页
International Journal of Blood Transfusion and Hematology
参考文献34
-
1Quach H, Ritchie D, Stewart AK, et al. Mechanism of action of immunomodulatory drugs ( IMiDS ) in multiple myeloma. Leukemia,2010,24(1) :22-32.
-
2Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature, 2011,480 ( 7378) : 480-489.
-
3Houet L, Veelken H. Active immunotherapy of multiple myeloma. Eur J Cancer,2006,42(11) :1658 -1660.
-
4Bogen B, Malissen B, Haas W. Idiotype-specific T ceil clones that recognize syngeneic immunoglobulin fragments in the context of class Ⅱ molecules. Eur J Immunol,1986,16(11) :1373-1878.
-
5Bogen B, Schenck K, Munthe LA, et al. Deletion of idiotype( Id)- specific T cells in multiple myeloma. Acta Oncol, 2000, a9 (7) : 783-788.
-
6Brown RD,Pope B,Murray A,et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-betal and interleukin-10. Blood, 2001, 98 (10) : 2992-2998.
-
7Abdalla AO, Kokhaei P, Hansson L, et al. Idiotype vaccination in patients with myeloma reduced circulating myeloma eells(CMC). Ann 0ncol,2008 ,19(6) :1172-1179.
-
8Hong S, Qian J, I,i H, et al. CpG or IFN-a are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma. Cancer lmmunol Immunother, 2012,61 (4) :561-571.
-
9Hollander N. Current vaccination strategies for the treatment of B-cell lymphoma and multiple myeloma. Crit Rev ImmunoI, 2009,29(5) :399-418.
-
10Neelapu SS, Munshi NC, Jagannath S, et al. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma. Bone Marrow Transplant,2005,36(4) :315-323.
-
1李芳.妇科肿瘤的特异性主动免疫治疗进展[J].国外医学（妇产科学分册）,2003,30(1):41-44.
-
2乔健.肿瘤特异性主动免疫治疗研究进展[J].国外医学（肿瘤学分册）,1994,21(3):155-157.
-
3张剑军（综述）,刘鲁明（审校）.胰腺癌免疫治疗进展[J].国际肿瘤学杂志,2007,34(1):58-61. 被引量：3
-
4何爱丽,赵万红.IL-2及/或GM-CSF在血液系统恶性肿瘤主动免疫治疗中的作用研究进展[J].国外医学（输血及血液学分册）,1999,22(3):174-176.
-
5田思源,徐爱兵,沈茜,蔡鸿宇,周元.吉西他滨联合奥沙利铂治疗晚期原发性肝癌的临床观察[J].肿瘤基础与临床,2012,25(1):52-53. 被引量：12
-
6卢凯华,仇金荣,黄普文,穆庆霞,王榕生,朱陵君,束永前,刘宝瑞.吉西他滨联合铂类药物治疗晚期胰腺癌的疗效观察[J].中国基层医药,2004,11(10):1153-1154. 被引量：2
-
7王广征.胰腺癌切除术后吉西他滨辅助化疗疗效观察[J].山东医药,2009,49(38):95-96. 被引量：3
-
8孙润蛟,金仙玉.人附睾蛋白4在卵巢上皮性癌诊断中的应用[J].中国医师进修杂志,2014,37(9):69-71.
-
9葛宁灵,叶胜龙,刘银坤,郑宁,孙瑞霞,汤钊猷.白细胞介素-12基因再修饰基因瘤苗免疫小鼠的脾细胞过继治疗肝癌[J].中华实验外科杂志,2003,20(1):21-23. 被引量：2
-
10郭宁.肿瘤抗原特异性主动免疫治疗研究进展[J].国外医学（肿瘤学分册）,1996,23(4):193-196. 被引量：3
